Our Team

The work of the Huntington’s Disease Foundation is facilitated by our leadership team and guided by our Board of Directors and our Scientific Advisory Board.

Leadership Team

Meghan Donaldson

Meghan joined the HDF after a successful banking career with Brown Brothers Harriman & Co., First Chicago Bank, N.A, Credit Suisse First Boston, and Macquarie Group. Meghan has had a life-long interest in Huntington’s disease and is passionate about finding a cure for HD and helping families affected by HD. At the HDF, Meghan focuses on general business management and fundraising. Meghan holds an MBA from the University of Chicago Booth School of Business and a BS in Mathematics from William Smith College.

Meghan Donaldson

Chief Executive Officer

Nancy S. Wexler, PhD

President, Huntington’s Disease Foundation
Higgins Professor of Neuropsychology
Columbia University Vagelos College of Physicians and Surgeons
Royal College of Physicians, London
American Academy of Arts and Sciences
National Academy of Medicine

Nancy S. Wexler, PhD, has devoted her career to finding treatments and a cure for Huntington’s disease. Her pioneering field work in Venezuela with the largest known family with HD led to the discovery of a genetic marker in 1983. This achievement validated a new approach to mapping genes, including many other disease genes, and helped launch the Human Genome Project. It also made possible a predictive test for HD. Following the marker discovery, she helped organize and lead the Huntington’s Disease Foundation’s historic international collaborative research group that, in 1993, identified the expansion in the HD gene itself.

Nancy has also led efforts to ensure fair use of genetic information and improve care for those living with HD and other neurodegenerative conditions. She served as executive director of a landmark congressional commission on Huntington’s in the 1970s and, in the 1990s, chaired the first Ethical, Legal, and Social Issues Working Group (ELSI) of the Human Genome Project. All these achievements led to numerous awards and honors, including the Franklin Prize in Life Science (2007), the Cold Spring Harbor Double Helix Medal (2019), and the Lasker Prize for Public Service (1993). She currently lives with HD in New York City.

Nancy S. Wexler, PhD

President

Tim Kelleher

Tim has combined public and private accounting experience specializing in supporting tax-exempt and non-profit organizations. Currently with Carey & Co. as CFO since 2015, Tim is acting CFO for HDF with Carey & Co. providing the bookkeeping services. He has worked with several clients, most recently serving the Author’s Guild, Girl Scouts of Greater New York, CFO and Controller at the American Lung Association, Damon Runyon Cancer Research Foundation, and Brick Church. Tim received his BS in Accounting from Holy Cross College and is a CPA.

Tim Kelleher

Chief Financial Officer

Julie Porter

Julie oversees the administration of the Huntington’s Disease Foundation. She plays a key role in fundraising, advocacy, outreach, communications, event and Workshop coordination. Julie also played a unique role in the oversight of the data collected during the HDF’s Venezuelan Project. She has been with the HDF since 1996.

Julie Porter

Director of Administration

Sarah Hernandez, PhD

Dr. Sarah Hernandez oversees the Foundation’s scientific research portfolio by managing the grants program, acting as the scientific liaison, and coordinating scientific programming through webinars, workshops, and conferences. Sarah enthusiastically supports the mission of the HDF, working closely with its Scientific Advisory Board to identify the most promising research and accelerate treatments for Huntington’s disease.

Sarah learned at a young age that her family was affected by Huntington’s disease, motivating her to learn more and inspiring her to become a scientist. In 2015, she received a PhD in Biology and Biotechnology from Worcester Polytechnic Institute. For her postdoctoral studies, she joined the lab of renowned Huntington’s disease scientist Leslie Thompson, PhD, at the University of California, Irvine and Chair-Elect, HDF Scientific Advisory Board. There she worked on understanding the molecular consequences of Huntington’s disease to cells of the brain using stem cells and fruit flies. In 2021, she was honored as the recipient of the Huntington’s Disease Foundation Nancy S. Wexler Young Investigator Prize, presented to a researcher whose work represents the highest caliber of excellence, diligence, and creative thinking. Additionally, Sarah is an editor for HDBuzz, writing articles about Huntington’s disease-related science and research news in plain language for the patient community.

Sarah Hernandez, PhD

Director of Research Programs

COMING SOON

Our Director of Development oversees all fundraising and philanthropic efforts of the Foundation, working to strengthen relationships with donors, supporters, and partners while strategizing and executing initiatives to further the mission of the HDF.

COMING SOON

Director of Development

Debra Karrat

Debra supports the Huntington’s Disease Foundation in marketing, communications, strategy and execution. Debra has extensive marketing, branding and strategy experience in both product and service industries leading well-known brands including Tumi, L’Oreal and Wella. She founded her marketing company in 2003 and worked for many clients as both a consultant, marketing director and CMO.

Debra Karrat

Marketing/Communications

Mary Jane Goode

At the HDF, Mary Jane focuses on finance and human resources. Before entering the nonprofit sector, Mary Jane spent 20 years in banking with Banc of America Securities, Salomon Smith Barney and others. She holds an MBA from UNC Kenan-Flagler Business School and a BA in Economics from Davidson College.

Mary Jane Goode

Finance and HR

Karen Newman

Chair, Board of Directors

Board of Directors

Scientific Advisory Board